Andrew Slee

2.0k total citations
47 papers, 1.6k citations indexed

About

Andrew Slee is a scholar working on Molecular Biology, Periodontics and Epidemiology. According to data from OpenAlex, Andrew Slee has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Periodontics and 8 papers in Epidemiology. Recurrent topics in Andrew Slee's work include Oral microbiology and periodontitis research (11 papers), Oral Health Pathology and Treatment (7 papers) and Probiotics and Fermented Foods (4 papers). Andrew Slee is often cited by papers focused on Oral microbiology and periodontitis research (11 papers), Oral Health Pathology and Treatment (7 papers) and Probiotics and Fermented Foods (4 papers). Andrew Slee collaborates with scholars based in United States, United Kingdom and Australia. Andrew Slee's co-authors include J.M. Tanzer, David C. Eustice, Janet S. Kerr, Ian Zajac, Shaker A. Mousa, Martin Forbes, Mark A. Wuonola, Walter A. Gregory, Patricia Feldman and David R. Brittelli and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Andrew Slee

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Slee United States 26 593 398 325 206 201 47 1.6k
Valerie A. Schroeder United States 22 634 1.1× 377 0.9× 184 0.6× 46 0.2× 126 0.6× 45 1.7k
Fuminori Kato Japan 19 536 0.9× 160 0.4× 273 0.8× 69 0.3× 68 0.3× 43 1.2k
Zoltán Baráth Hungary 21 542 0.9× 164 0.4× 72 0.2× 87 0.4× 119 0.6× 80 1.5k
Shahper N. Khan India 22 796 1.3× 278 0.7× 83 0.3× 150 0.7× 90 0.4× 55 1.7k
Oriana Simonetti Italy 28 695 1.2× 115 0.3× 271 0.8× 38 0.2× 336 1.7× 150 2.5k
Michael R. Brown United Kingdom 19 679 1.1× 98 0.2× 107 0.3× 56 0.3× 150 0.7× 35 1.4k
Ali Azghani United States 25 705 1.2× 92 0.2× 123 0.4× 62 0.3× 147 0.7× 45 1.7k
I. Ginsburg Israel 20 347 0.6× 77 0.2× 209 0.6× 106 0.5× 148 0.7× 67 1.3k
Helena Sztajer Germany 27 1.4k 2.4× 131 0.3× 237 0.7× 495 2.4× 225 1.1× 43 2.2k
Hideaki Nagamune Japan 24 745 1.3× 552 1.4× 191 0.6× 53 0.3× 209 1.0× 134 1.8k

Countries citing papers authored by Andrew Slee

Since Specialization
Citations

This map shows the geographic impact of Andrew Slee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Slee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Slee more than expected).

Fields of papers citing papers by Andrew Slee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Slee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Slee. The network helps show where Andrew Slee may publish in the future.

Co-authorship network of co-authors of Andrew Slee

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Slee. A scholar is included among the top collaborators of Andrew Slee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Slee. Andrew Slee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mueller, Lauren, Roseanne S. Wexler, David A. Lovejoy, Robert B. Stein, & Andrew Slee. (2024). Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice. Psychopharmacology. 241(8). 1565–1575. 1 indexed citations
2.
Wexler, Roseanne S., et al.. (2003). The Hollow Fiber Assay. Lung Cancer. 74. 545–566. 3 indexed citations
3.
Kerr, Janet S., Andrew Slee, & Shaker A. Mousa. (2002). The αvintegrin antagonists as novel anticancer agents: an update. Expert Opinion on Investigational Drugs. 11(12). 1765–1774. 48 indexed citations
4.
Gonzales, Armando, et al.. (2002). An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat. Journal of Neuroscience Methods. 113(1). 51–58. 51 indexed citations
5.
Wexler, Roseanne S., et al.. (2001). Regulation of gene expression and cell growth in vivo by tetracycline using the hollow fiber assay.. PubMed. 21(2A). 869–72. 8 indexed citations
6.
Hobbs, Frank W., et al.. (2001). Oxazolidinones Mechanism of Action: Inhibition of the First Peptide Bond Formation. Journal of Biological Chemistry. 276(40). 37199–37205. 33 indexed citations
7.
Mousa, Shaker A., Jeffrey M. Bozarth, Ulhas P. Naik, & Andrew Slee. (2001). Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban. British Journal of Pharmacology. 133(3). 331–336. 41 indexed citations
8.
Wexler, Roseanne S., et al.. (2000). The hollow fiber assay: continued characterization with novel approaches.. PubMed. 20(2A). 903–11. 40 indexed citations
9.
Wong, Pancras C., Earl J. Crain, Robert M. Knabb, et al.. (2000). Nonpeptide Factor Xa Inhibitors II. Antithrombotic Evaluation in a Rabbit Model of Electrically Induced Carotid Artery Thrombosis. Journal of Pharmacology and Experimental Therapeutics. 295(1). 212–218. 25 indexed citations
10.
Copeland, Robert A., Jovita Marcinkeviciene, Tasir S. Haque, et al.. (2000). Helicobacter pylori-selective Antibacterials Based on Inhibition of Pyrimidine Biosynthesis. Journal of Biological Chemistry. 275(43). 33373–33378. 56 indexed citations
11.
Kerr, Janet S., Andrew Slee, & Shaker A. Mousa. (2000). Small molecule αv integrin antagonists: novel anticancer agents. Expert Opinion on Investigational Drugs. 9(6). 1271–1279. 36 indexed citations
12.
Mousa, Shaker A., Richard E. Olson, Jeffrey M. Bozarth, et al.. (1998). Oral Antiplatelet Efficacy and Specificity of a Novel Nonpeptide Platelet GPIIb/IIIa Receptor Antagonist, DMP 802. Journal of Cardiovascular Pharmacology. 32(2). 169–176. 13 indexed citations
13.
Gregory, Walter A., David R. Brittelli, Hollis S. Kezar, et al.. (1991). ChemInform Abstract: Antibacterials. Synthesis and Structure‐Activity Studies of 3‐Aryl‐2‐ oxooxazolidines. Part 2. The “A” Group.. ChemInform. 22(8). 3 indexed citations
14.
Gregory, Walter A., David R. Brittelli, Mark A. Wuonola, et al.. (1989). Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The B group. Journal of Medicinal Chemistry. 32(8). 1673–1681. 141 indexed citations
15.
Wentland, Mark P., et al.. (1988). In vitro dental plaque inhibitory properties of a series of N-[1-alkyl-4(1H)-pyridinylidene]alkylamines. Journal of Medicinal Chemistry. 31(10). 2024–2027. 3 indexed citations
16.
Eustice, David C., Patricia Feldman, & Andrew Slee. (1988). The mechanism of action of DuP 721, a new antibacterial agent: Effects on macromolecular synthesis. Biochemical and Biophysical Research Communications. 150(3). 965–971. 50 indexed citations
17.
Eustice, David C., Patricia Feldman, Ian Zajac, & Andrew Slee. (1988). Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrobial Agents and Chemotherapy. 32(8). 1218–1222. 97 indexed citations
18.
Slee, Andrew & J.M. Tanzer. (1983). The repressible metabolism of sorbitol (d-glucitol) by intact cells of the oral plaque-forming bacterium Streptococcus mutans. Archives of Oral Biology. 28(9). 839–845. 17 indexed citations
19.
Slee, Andrew & J.M. Tanzer. (1982). Sucrose transport by Streptococcus mutans. Evidence for multiple transport systems. Biochimica et Biophysica Acta (BBA) - Biomembranes. 692(3). 415–424. 39 indexed citations
20.
Slee, Andrew & J.M. Tanzer. (1978). Selective medium for isolation of Eikenella corrodens from periodontal lesions. Journal of Clinical Microbiology. 8(4). 459–462. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie A. Schroeder Breakdown of academic impact, for papers by Fuminori Kato Breakdown of academic impact, for papers by Zoltán Baráth Breakdown of academic impact, for papers by Shahper N. Khan Breakdown of academic impact, for papers by Oriana Simonetti Breakdown of academic impact, for papers by Michael R. Brown Breakdown of academic impact, for papers by Ali Azghani Breakdown of academic impact, for papers by I. Ginsburg Breakdown of academic impact, for papers by Helena Sztajer Breakdown of academic impact, for papers by Hideaki Nagamune
Rankless by CCL
2026